Impact of Iron Deficiency on HBA2 Levels and its Implications in Thalassemia Trait Detection
International Journal of Pharmaceutical Quality Assurance · 2025
DOI: 10.25258/ijpqa.16.1.51 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, 2025. Verfasst von Shipra Singh und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Thalassemia trait screening often relies on the quantification of Hemoglobin A2 (HbA2) levels, which are typically elevated in beta-thalassemia carriers. However, iron deficiency, a highly prevalent condition in India, especially among females, has been postulated to reduce HbA2 levels, potentially leading to falsenegative screening results. Understanding the impact of iron deficiency on HbA2 values is critical to ensuring accurate detection of thalassemia carriers, especially in population-level screening programs.
Objectives
To evaluate the effect of iron deficiency on HbA2 levels and determine whether iron deficiency can mask the diagnosis of beta-thalassemia trait in individuals undergoing screening.
Methods
This observational cross-sectional study was conducted in the Department of Pathology, Darbhanga Medical College and Hospital, Bihar, from August 2022 to July 2023. A total of 130 individuals aged 18–40 years undergoing anemia evaluation or thalassemia screening were included. Participants were grouped into irondeficient and non-iron-deficient groups based on serum ferritin, transferrin saturation, and complete blood count findings. HbA2 quantification was done using high-performance liquid chromatography (HPLC). Statistical analysis was performed to assess the correlation between iron status and HbA2 levels.
Results
Out of 130 participants, 72 were iron-deficient while 58 had normal iron stores. The mean HbA2 level in the iron-deficient group was 2.3 ± 0.4%, significantly lower than the non-iron-deficient group which had a mean HbA2 level of 3.1 ± 0.5% (p < 0.001). Among iron-deficient individuals with suspected thalassemia trait, HbA2 levels were found to be within normal or borderline ranges, indicating the possibility of masked diagnosis. Upon iron repletion and re-evaluation in a subset, HbA2 levels rose significantly, unmasking latent betathalassemia trait in some cases.
Conclusion
Iron deficiency significantly lowers HbA2 levels and may obscure the diagnosis of beta-thalassemia trait in screening programs. Screening for thalassemia should either follow correction of iron deficiency or incorporate parallel iron status assessment to avoid misclassification. This is particularly relevant in highprevalence regions like Bihar where iron deficiency anemia is common.
Zitieren
APA
Singh, S., & Rajan, R. K. (2025). Impact of Iron Deficiency on HBA2 Levels and its Implications in Thalassemia Trait Detection. International Journal of Pharmaceutical Quality Assurance. https://doi.org/10.25258/ijpqa.16.1.51
Vancouver
Singh S, Rajan RK. Impact of Iron Deficiency on HBA2 Levels and its Implications in Thalassemia Trait Detection. International Journal of Pharmaceutical Quality Assurance. 2025. doi:10.25258/ijpqa.16.1.51
BibTeX
@article{Singh2025,
author = {Singh, Shipra and Rajan, Ranjan Kumar},
title = {Impact of Iron Deficiency on HBA2 Levels and its Implications in Thalassemia Trait Detection},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2025},
doi = {10.25258/ijpqa.16.1.51}
}
EUVIMED